BRIEF-Uniqure announces preclinical data supporting gene therapy program, AMT-130 By: Reuters: Company News March 22, 2016 at 11:11 AM EDT * Says publication of preclinical data supporting its proprietary Huntington's disease gene therapy program, AMT-130 Read More >> Related Stocks: Uniqure Ord Shs